David Koch, Billionaire Donor to Conservative Causes and Cancer Research, Dies
WASHINGTON — Billionaire industrialist David H. Koch, who with his older brother, Charles, transformed American politics by pouring their riches into conservative causes, has died at age 79.
Charles Koch announced the death in a statement, which gave no cause but noted that David Koch had suffered from prostate cancer in the past.
According to published reports, David Koch’s fortune at his death was about $42.2 billion, almost all of it derived from his 42 percent stake in the global family business, Koch Industries.
A well-known philanthropist, Koch led the family into politics in 1980 when he ran as the Libertarian Party’s candidate for vice president.
In the decades since, the Koch brothers’ fortune helped fuel the rise of the Tea Party movement and a resurgence of the far-right wing of the Republican Party.
In the process, they played key roles in loosening limits on campaign contributions while continually promoting conservative candidacies, advocacy groups and think tanks like Americans for Prosperity and the American Legislative Exchange Council, an organization of conservative state legislators and corporate lobbyists.
The latter organization specializes in drafting model state legislation that members may customize for introduction as proposed laws to cut taxes, combat illegal immigration, loosen environmental regulations, weaken labor unions and oppose gun laws.
In a 2012 op-ed in the New York Post, David Koch wrote that he was taught from a young age that involvement in the public discourse is a civic duty.
“Each of us has a right — indeed, a responsibility, at times — to make his or her views known to the larger community in order to better form it as a whole. While we may not always get what we want, the exchange of ideas betters the nation in the process,” he said.
Although long a thorn in the side of Democrats, the Kochs refused to endorse Donald Trump in 2016, saying the then Republican presidential nominee was not sufficiently conservative.
But by then, David Koch, who had been battling prostate cancer for 18 years, was backing away from politics.
“I like to engage where my part makes a difference,” he told The Weekly Standard in 2012. “I have a point of view. When I pass on, I want people to say he did a lot of good things, he made a real difference, he saved a lot of lives in cancer research.”
In The News
In The News
WASHINGTON - The House passed legislation that would decriminalize cannabis at the federal level -- the first time either chamber of Congress has voted on such a measure. And significantly, the measure received bipartisan support. When the figurative smoke cleared, the Marijuana Opportunity Reinvestment & Expungement... Read More
WASHINGTON - House Democrats made history on Thursday when the caucus voted to make Reps. Gregory Meeks, of New York, and David Scott, of Georgia, the first African-Americans to chair, respectively, the chamber's Foreign Affairs and Agriculture Committees. Meeks, who was the third-ranking member of the... Read More
In a virtual roundtable event co-hosted Tuesday by the Hutchins Center on Fiscal & Monetary Policy and the Peterson Institute for International Economics, economists discussed what economic policies should be prioritized by the in-coming Biden Administration and Congress. The panelists who participated in the event, presented... Read More
WASHINGTON -- Drug policy analysts told a congressional committee Thursday that the U.S. government has largely failed to stop illegal drug smuggling because of an unfocused strategy against the cartels. Instead, they recommended flexibility that seeks solutions based on local conditions. In one example analysts mentioned... Read More
WASHINGTON — Since the end of the Cold War, the relationship between the United States and Russia has been complicated, often described more as competitive and conflicting than cooperative. Yet a new administration in the U.S. could bring a fresh opportunity to balance some elements of... Read More
WASHINGTON – Third Way, a Washington D.C.- based think tank, launched its inaugural “Wine with Wonks” virtual series this week that features scholars from its ACADEMIX Upshot series in an effort to promote their research and explore various education topics in a round-robin style of discussion... Read More